Budget impact of eribulin in metastatic breast cancer in Russian Federation
Breast cancer is one of the most wide spread oncological disease and metastatic breast cancer is very severe, because of its high resistance. One of the recent drugs aimed for this group of patients is еribulin, which is microtubules dynamics inhibitor, leading to non-functional tubuline complex for...
Saved in:
Main Authors: | S. K. Zyryanov (Author), D. Yu. Belousov (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy
by: Doherty MK, et al.
Published: (2015) -
Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
by: Doherty MK, et al.
Published: (2015) -
Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea
by: Tremblay G, et al.
Published: (2016) -
Prognostic significance of neutrophil to lymphocyte ratio in patients with metastatic breast cancer on the background of eribulin therapy
by: A. V. Zyuzyukina, et al.
Published: (2022) -
Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study
by: L. A. Tashireva, et al.
Published: (2022)